Metraipolis › archive › dc_95b7006147fb

Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial — Europe PMC PMID:42406777

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42406777
DOI
10.1093/humrep/deag106
License (as archived)
solo-consultazione
Archived
2026-10-16T07:57:55.346Z
SHA-256 of the archived text
26b6ebd85b0c1e53552197a85db88463c1c029a0eb3c50033c9a17c01927d730
Stable URL of this page
https://metraipolis.com/documento/dc_95b7006147fb

How to cite

Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial — Europe PMC PMID:42406777 — Europe PMC (en), https://europepmc.org/article/MED/42406777 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_95b7006147fb (Metraipolis archive dc_95b7006147fb, sha256 26b6ebd85b0c1e53552197a85db88463c1c029a0eb3c50033c9a17c01927d730)
BibTeX
@misc{dc95b7006147fb,
  title = {Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial — Europe PMC PMID:42406777},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42406777},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_95b7006147fb; sha256 26b6ebd85b0c1e53552197a85db88463c1c029a0eb3c50033c9a17c01927d730},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42406777. Agents can read the archived copy with the MCP tool read_document.